We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sensor Measures Affect of Physical Activity on Diabetes

By LabMedica International staff writers
Posted on 11 Feb 2009
An under-the-skin glucose sensor measures the affect of physical activity on diabetes. The sensor consists of a tiny electrode connected to a transmitter, which is attached to the skin with an adhesive patch.

The sensor can take nearly 300 readings per day and is to be used to monitor people with diabetes' glucose levels in a new study. Diabetes experts based at Southampton General Hospital (UK) will fit the tiny devices to participants' stomachs and use them in conjunction with watch-like armbands, which will check participants' physical activity. The study, the first of its kind in the United Kingdom, will determine how much of an impact exercise has on blood glucose levels while also taking diet and insulin intake into account.

Led by Prof. Christopher Byrne and Dr. Andrew Chipperfield, the study should shed new light on the management of type 1 diabetes. Thirty volunteers aged between 18 and 75 will be supplied with the sensor and armband. Weighing less than a 7 g, the waterproof electrode and transmitter will be replaced every three days. The physical activity armband will be worn for two blocks of 2 weeks during the 12-month study to record continuous data, which can then be downloaded electronically.

Dr. Victoria King, research manager at Diabetes UK said, "Physical activity is an essential part of managing type 1 diabetes and protecting against the serious complications of the condition such as heart disease, stroke, kidney failure, blindness, and amputation. We hope that this study will equip people with type 1 diabetes with the information they need to make pragmatic decisions about physical activity and how it is likely to affect their blood glucose control. This in turn will help to protect both their short- and long-term health.”

Related Links:

Southampton General Hospital



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Liquid Based Cytology Production Machine
LBP-4032
New
Hepatitis B Virus Test
HBs Ab – ELISA

Latest Clinical Chem. News

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability